Table 1.
Primary Indications | |
Previous intracranial hemorrhage | |
High risk of intracranial hemorrhage | |
Previous major GI bleeding | |
End-stage renal disease | |
Potential Indications | |
Hematologic disorders | |
Advisable prolonged anti-platelet therapy | |
Recurrent events despite optimal anticoagulation | |
Non-compliant patients | |
Young patients (<55 years old, CHA2DS2-VASC > 1) |